FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE CONCENTRATIONS
Disclosed herein is a high-effective-concentration cannabinoid-based vape oil that is flowable within a vape device. The high-effective-concentration cannabinoid-based vape oil comprises a cannabinoid-based incipient and a cannabinoid-based target component. The cannabinoid-based incipient has an in-situ concentration that is less than the saturation concentration of the cannabinoid-based incipient. The cannabinoid-based target component has an in-situ concentration that is less than the saturation concentration of the cannabinoid-based target component. The in-situ concentration of the cannabinoid-based incipient and the in-situ concentration of the cannabinoid-based target component, taken together, is greater than the saturation concentration of the cannabinoid-based target component. The cannabinoid-based target component has an in-actio concentration that is greater than the saturation concentration of the cannabinoid-based target component. As such, the cannabinoid-based vape oil has a high-effective concentration of the cannabinoid-based target component.
1 - 48 .(canceled)
49 . A high-effective-concentration cannabinoid-based vape oil composition, comprising:
a cannabinoid-based incipient; and
a cannabinoid-based target component,
wherein:
the cannabinoid-based incipient has an in-situ concentration that is less than the saturation concentration of the cannabinoid-based incipient,
the cannabinoid-based target component has an in-situ concentration that is less than the saturation concentration of the cannabinoid-based target component,
the in-situ concentration of the cannabinoid-based incipient and the in-situ concentration of the cannabinoid-based target component, taken together, is greater than the saturation concentration of the cannabinoid-based target component, yet the cannabinoid-based vape oil is flowable, and
the cannabinoid-based target component has an in-actio concentration that is greater than the saturation concentration of the cannabinoid-based target component, such that the cannabinoid-based vape oil has a high-effective concentration of the cannabinoid-based target component.
50 . The composition of claim 49 , wherein the cannabinoid-based incipient is cannabidiolic acid (CBDA) and the cannabinoid-based target component is cannabidiol (CBD).
51 . The composition of claim 50 , wherein the cannabinoid-based incipient and the cannabinoid-based target component are present in a ratio of between about 1.6:1.0 and about 1.0:1.0, on a weight basis.
52 . The composition of claim 50 , wherein the cannabinoid-based incipient accounts for between about 20 wt. % and about 70 wt. % of the composition.
53 . The composition of claim 50 , wherein the cannabinoid-based target component accounts for between about 30 wt. % and about 50 wt. % of the composition.
54 . The composition of claim 52 , wherein the cannabinoid-based target component accounts for between about 30 wt. % and about 50 wt. % of the composition.
55 . The composition of claim 54 , wherein the cannabinoid-based incipient accounts for between about 45 wt. % and about 55 wt. % of the composition and the cannabinoid-based target component accounts for between about 30 wt. % and about 40 wt. % of the composition.
56 . The composition of claim 55 , wherein the cannabinoid-based incipient and/or the cannabinoid-based target component is from a hemp extract.
57 . The composition of claim 50 , wherein the cannabinoid-based incipient and the cannabinoid-based target component are present in a ratio of between about 1.0:1.3 and about 1.0:2.4, on a weight basis.
58 . The composition of claim 57 , wherein the cannabinoid-based incipient accounts for between about 26 wt. % and about 40 wt. % of the composition and the cannabinoid-based target component accounts for between about 50 wt. % and about 63 wt. % of the composition.
59 . The composition of claim 50 , wherein the cannabinoid-based incipient accounts for about 30 wt. % of the composition.
60 . The composition of claim 50 , wherein the cannabinoid-based target component accounts for about 60 wt. % of the composition.
61 . The composition of claim 59 , wherein the cannabinoid-based target component accounts for about 60 wt. % of the composition.
62 . The composition of claim 61 , wherein the cannabinoid-based incipient and/or the cannabinoid-based target component is from a distillate.
63 . A cannabinoid composition, comprising:
cannabidiolic acid (CBDA); and
cannabidiol (CBD);
wherein:
the CBDA accounts for between about 20.0 wt. % and about 70.0 wt. % of the composition,
the CBD accounts for between about 30.0 wt. % and about 50.0 wt. % of the composition, and
the composition is flowable within a vape device.
64 . The composition of claim 63 , wherein the CBDA and the CBD are present in a ratio of between about 1.6:1.0 and about 1.0:1.0, on a weight basis.
65 . The composition of claim 63 , wherein the CBDA accounts for between about 45 wt. % and about 55 wt. % of the composition.
66 . The composition of claim 65 , wherein the CBD accounts for between about 30 wt. % and about 40 wt. % of the composition.
67 . The composition of claim 66 , wherein the CBDA and/or CBD is from a hemp extract.
68 . A cannabinoid composition, comprising:
cannabidiolic acid (CBDA); and
cannabidiol (CBD);
wherein:
the CBDA accounts for between about 26 wt. % and about 40 wt. % of the composition,
the CBD accounts for between about 50 wt. % and about 63 wt. % of the composition, and the composition is flowable within a vape device.
69 . The composition of claim 68 , wherein the CBDA and the CBD are present in a ratio of between about 1.0:1.3 and about 1.0:2.4.
70 . The composition of claim 68 , wherein the cannabinoid-based incipient accounts for about 30 wt. % of the composition.
71 . The composition of claim 68 , wherein the cannabinoid-based target component accounts for about 60 wt. % of the composition.
72 . The composition of claim 70 , wherein the cannabinoid-based target component accounts for about 60 wt. % of the composition.
73 . The composition of claim 72 , wherein the CBDA and/or CBD is from a distillate.